- 029-86354885
- 18392009562
Auristatin F是细胞毒性分子,微管蛋白修饰分子,强效抗**活性,MMAF的类似物以及在抗体药物偶连体开发中作为毒素分子。
英文名称:Auristatin F
中文名称:奥瑞他汀 F
CAS:163768-50-1

抗体药物偶联物(Antibody-drug conjugate, ADC)是通过化学键将具有生物活性的细胞毒药物连接到单克隆抗体(mAb)上,单克隆抗体(mAb)作为载体将细胞毒药物靶向运输到目标细胞中发挥作用的一类药物。既具有细胞毒药物杀伤力强大的特点,又结合了重组单克隆抗体(mAb)高度的靶向性,稳定性和有利的药代动力学特征,主要表现为:治疗效力强;特异性高;免疫原性弱,不容易产生抗药性;血清中循环时间长(短于单抗);对非靶点毒性弱等。
相关产品:
Dolastatin 10 110417-88-4 微管蛋白聚合抑制剂
Monomethyl Dolastatin 10 203849-91-6单甲基澳瑞他汀 D
Auristatin E 160800-57-7 一甲基澳瑞他汀
Monomethyl Auristatin E 474645-27-7微管相关抑制剂
Auristatin F 163768-50-1
Monomethyl Auristatin F 745017-94-1
HTI-286 228266-40-8
Tubulysin M 205304-86-5
Maytansinoid AP-3 66547-09-9
Maytansinol 57103-68-1
DM1 139504-50-0
DM4 799840-96-3
Boc-Val-Dil-Dap-OH
Boc-Val-Dil-Dap-Phe-OMe
Boc-Val-Dil-Dap-Doe
Boc-Val-Dil-Dap-Nrp
Boc-N-Me-Val-Val-Dil-Dap-OH
Tubulysin IM-1
Tubulysin IM-2
Tubulysin IM-3
Duocarmycin SA 152785-82-5
Duocarmycin TM
Duocarmycin MA
Duocarmycin DM
Nemorubicin 108852-90-0
PNU-159682 202350-68-3
Calicheamicin g1 108212-75-5
Acetyl-Calicheamicin g1 108212-76-6
a-Amanitin 23109-05-9
PBD-dimer 1222490-34-7
OSu-Glu-vc-PAB-MMAE
SMCC-DM1
SPDB-DM4
OSu-PEG4-vc-PAB-DMEA
Duocarmycin SA
Mylotarg-linker
OSu-Glu-vc-PAB-MMAD
Sulfo-SPDB-DM4
IMGN779-linker
OSu-PEG4-vc-PAB-DMEA
Duocarmycin TM
OSu-PEG4-vc-PAB-DMEA
Duocarmycin DM
MC-vc-PAB-MMAE
MC-MMAF
MC-DM1
MC-MMD-10
MA-PEG4-vc-PAB-DMEA-duocarmycin SA
MC-vc-PAB-C6-a-amanitin
MC-cleavable-linker-a-amanitin
MC-vc-PAB-DMEA-(PEG2)-duocarmycin SA
MC-vc-PAB-Tubulysin M
MC-va-PAB-MMAD
MA-PEG4-VC-PAB-DMAE-PNU159682
MA-PEG4-VA-PBD
MC-vc-PAB-MMAF
MC-vc-PAB-MMAD
MC-vc-PAB-Auristatin 0101
MA-PEG8-VA-PAB-SG3199
CL2A-SN 38
MC-GGFG-DX8951
MEDI4276_linker payload
MA-PEG4-vc-PAB-DMEA-duocarmycin TM
MC-vc-PAB-(PEG2)-duocarmycin TM
MA-PEG4-vc-PAB-DMEA-duocarmycin DM
MC-vc-PAB-(PEG2)-duocarmycin DM
DGN549
MPB-vc-PAB-MMAE
MPB-MMAF
DBCO-PEG4-vc-PAB-MMAE
DBCO-PEG4-MMAF
DBCO-PEG4-Ahx-DM1
DBCO-PEG4-vc-PAB-Duocarmycin SA
DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin SA
DBCO-PEG4-VA-PBD
DBCO-PEG4-vc-PAB-MMAF
DBCO-PEG4-vc-PAB-MMAD
DBCO-PEG4-vc-PAB-Duocarmycin TM
DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin TM
DBCO-PEG4-vc-PAB-Duocarmycin DM
DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin DM
DBCO-PEG4-VC-PAB-DMAE-PNU159682
DBCO-PEG4-DMAE-PNU159682
DBCO-PEG4-GGFG-DX8951
DBCO-PEG4-vc-PAB-Ahx-DM1
DBCO-PEG8-VA-PAB-SG3199
Gly3-vc-PAB-MMAE
Gly3-MMAF
Gly5-Ahx-DM1
PNU159682-EDA-Gly3
ADC pre-screening kit A
Protein A-DM1
Protein A-MMAE
Protein A-MMAF
Protein A-Duocarmycin
Protein A-Calicheamicin
Protein A-PBD
ADC pre-screening kit G
Protein G-DM1
Protein G-MMAE
Protein G-MMAF
Protein G-Duocarmycin
Protein G-Amanitin
Protein G-Amanitin
Rabbit Anti-vc-PAB-MMAE pAb
Mouse Anti-vc-PAB-MMAE mAb (B11F11)
Rabbit Anti-MMAF pAb
Mouse Anti-MMAF mAb (F3B11)
Mouse Anti-MMAE / F mAb (B12A2)
Mouse Anti-MMAE /F mAb (C12A1)
Rabbit Anti-DM1/4 pAb
Mouse Anti-DM1/4 mAb (F1D5)
Mouse Anti-DM1/4 mAb (G2F3)
Rabbit Anti-Calicheamicin pAb
Mouse Anti-Calicheamicin mAb (B1G9)&
序号 | 新闻标题 | 浏览次数 | 作者 | 发布时间 |
---|---|---|---|---|
1 | 抗氧化小分子70831-56-0,菊苣酸Cichoric Acid,6537-80-0的制备过程 | 893 | 瑞禧生物 | 2023-03-30 |
2 | 活性氧ROS小分子Dapsone,cas:80-08-0,氨苯砜的制备过程-瑞禧科研 | 798 | 瑞禧生物 | 2023-03-30 |
3 | HBPS-N3,Azide-PEG-HBPS,叠氮化超支化聚苯乙烯高分子聚合物的制备过程 | 925 | 瑞禧生物 | 2023-03-17 |
4 | l-PS-PhN3,Azide叠氮Azido偶联线性聚苯乙烯双链的制备过程 | 842 | 瑞禧生物 | 2023-03-17 |
5 | N3-PS-N3,Azido-PS-Azido/Azide,双叠氮官能团修饰聚苯乙烯的制备方法 | 801 | 瑞禧生物 | 2023-03-17 |
6 | PS-N3,Azido-PS,叠氮Azide修饰聚苯乙烯/高分子聚合物的制备过程 | 991 | 瑞禧生物 | 2023-03-17 |
7 | Azido-PEG2-t-Butylester/1271728-79-0,叠氮N3/ZAD修饰叔丁酯化合物的制备方法 | 824 | 瑞禧生物 | 2023-03-14 |